Live feed
Filing
SC 13G/A
SC 13G/A0001193125-18-023271·Ally Bridge Group Capital Partners II, L.P.
Schedule 13G ownership disclosure
DIFFUSION PHARMACEUTICALS IN
Security class unavailable · CUSIP: 253748206
Event date: 2018-01-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.6800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-023271
- Form type
- SC 13G/A
- Filer
- Ally Bridge Group Capital Partners II, L.P.
- CIK
- CIK 1609313
- Filed
- Jan 29, 2018
- Reporting period
- Jan 22, 2018
- Description
- Schedule 13G beneficial ownership